Evidence map›Paper›PMID 24080174›Full record

ArticleNeurobiology of aging2014

Assessment of Parkinson's disease risk loci in Greece.

Eleanna Kara, Georgia Xiromerisiou, Cleanthe Spanaki, Maria Bozi, Georgios Koutsis, Marios Panas, Efthimios Dardiotis, Styliani Ralli, Jose Bras, Christopher Letson and 16 more

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. The Association Analysis ofFrontiers in genetics · 2020
    Article
  7. Risk Factor Genes in Patients with Dystonia: A Comprehensive Review.Tremor and other hyperkinetic movements (New York, N.Y.) · 2018
    Review
  8. Genetic analysis of FGF20 in Chinese patients with Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 3 countries.

Eleanna KaraReta Lila Weston Laboratories and Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
Georgia Xiromerisiou
Cleanthe Spanaki
Maria Bozi
Georgios Koutsis
Marios Panas
Efthimios Dardiotis
Styliani Ralli
Jose Bras
Christopher Letson
Connor Edsall
Hannah Pliner
Sampath Arepalli
Kallirhoe Kalinderi
Liana Fidani
Sevasti Bostantjopoulou
Margaux F Keller
Nicholas W Wood
John Hardy
Henry Houlden
Leonidas Stefanis
Andreas Plaitakis
Dena Hernandez
Georgios M Hadjigeorgiou
Mike A Nalls
Andrew B Singleton
National Institute on Aging · USUniversity College London · GBAristotle University of Thessaloniki · GRNational and Kapodistrian University of Athens · GRUniversity of Thessaly · GRUniversity of Crete · GREginition Hospital · GRPapageorgiou General Hospital · GRTemple University · US

Funding

Genome wide SNP analysis in Parkinson's diseaseZIAAG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$12.6M
Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6M
MIDCAREER AWARD IN PATIENT ORIENTED RESEARCH ON AGINGK24AG000949 · NIA · YALE UNIVERSITY · PI INOUYE, SHARON K. · 1999 to 2009
$1.4M
Intramural NIH HHS Z01 AG000949Medical Research Council G0701075Medical Research Council G0802760Medical Research Council G1001253Medical Research Council G108/638Medical Research Council MC_G0901330Medical Research Council MC_G1000735Medical Research Council MC_PC_09003Medical Research Council MR/J004758/1NIA NIH HHS K24 AG000949Parkinson's UK G-0907Wellcome Trust 089698
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have been shown to be a powerful approach to identify risk loci for neurodegenerative diseases. Recent GWAS in Parkinson's disease (PD) have been successful in identifying numerous risk variants pointing to novel pathways potentially implicated in the pathogenesis of PD. Contributing to these GWAS efforts, we performed genotyping of previously identified risk alleles in PD patients and control subjects from Greece. We showed that previously published risk profiles for Northern European and American populations are also applicable to the Greek population. In addition, although our study was largely underpowered to detect individual associations, we replicated 5 of 32 previously published risk variants with nominal p values <0.05. Genome-wide complex trait analysis revealed that known risk loci explain disease risk in 1.27% of Greek PD patients. Collectively, these results indicate that there is likely a substantial genetic component to PD in Greece, similarly to other worldwide populations, that remains to be discovered.

Indexed as

Genome-Wide Association StudyAgedAllelesFemaleGenetic LociGenotypeGreeceHumansMaleMiddle AgedParkinson DiseaseRiskGCTAGeneticsGreeceGWASParkinson's diseaseRisk profiles

Identifiers

PMID24080174
PMCPMC3830580
OpenAlexW2023324727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.